ATE267611T1 - MENSCHLICHES ßMINOR VAULTß PROTEIN P193 - Google Patents
MENSCHLICHES ßMINOR VAULTß PROTEIN P193Info
- Publication number
- ATE267611T1 ATE267611T1 AT98926210T AT98926210T ATE267611T1 AT E267611 T1 ATE267611 T1 AT E267611T1 AT 98926210 T AT98926210 T AT 98926210T AT 98926210 T AT98926210 T AT 98926210T AT E267611 T1 ATE267611 T1 AT E267611T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- ßminor
- vaultß
- human
- vault protein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/011348 WO1999062547A1 (en) | 1998-06-03 | 1998-06-03 | HUMAN MINOR VAULT PROTEIN p193 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE267611T1 true ATE267611T1 (de) | 2004-06-15 |
Family
ID=22267215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98926210T ATE267611T1 (de) | 1998-06-03 | 1998-06-03 | MENSCHLICHES ßMINOR VAULTß PROTEIN P193 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1083927B1 (de) |
| JP (1) | JP2002516675A (de) |
| AT (1) | ATE267611T1 (de) |
| AU (1) | AU762371B2 (de) |
| CA (1) | CA2330833A1 (de) |
| DE (1) | DE69824206D1 (de) |
| WO (1) | WO1999062547A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003232200A1 (en) * | 2002-04-08 | 2003-10-20 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases |
| US8124109B2 (en) | 2008-05-15 | 2012-02-28 | The Regents Of The University Of California | Vault compositions for immunization against chlamydia genital infection |
| AU2010313112B2 (en) | 2009-11-02 | 2014-06-26 | The Regents Of The University Of California | Vault complexes for cytokine delivery |
| US8551781B2 (en) | 2009-11-19 | 2013-10-08 | The Regents Of The University Of California | Vault complexes for facilitating biomolecule delivery |
| EP2921555B1 (de) * | 2012-11-19 | 2019-01-02 | Japan Science And Technology Agency | Künstliche biopartikel und herstellungsverfahren dafür |
| CN112724253B (zh) * | 2021-03-09 | 2022-04-05 | 生工生物工程(上海)股份有限公司 | 抗人穹窿体蛋白的抗体及其应用 |
-
1998
- 1998-06-03 AU AU78103/98A patent/AU762371B2/en not_active Expired
- 1998-06-03 WO PCT/US1998/011348 patent/WO1999062547A1/en not_active Ceased
- 1998-06-03 AT AT98926210T patent/ATE267611T1/de not_active IP Right Cessation
- 1998-06-03 JP JP2000551802A patent/JP2002516675A/ja not_active Withdrawn
- 1998-06-03 DE DE69824206T patent/DE69824206D1/de not_active Expired - Fee Related
- 1998-06-03 CA CA002330833A patent/CA2330833A1/en not_active Abandoned
- 1998-06-03 EP EP98926210A patent/EP1083927B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69824206D1 (de) | 2004-07-01 |
| AU7810398A (en) | 1999-12-20 |
| EP1083927A4 (de) | 2002-01-02 |
| EP1083927B1 (de) | 2004-05-26 |
| WO1999062547A1 (en) | 1999-12-09 |
| JP2002516675A (ja) | 2002-06-11 |
| EP1083927A1 (de) | 2001-03-21 |
| AU762371B2 (en) | 2003-06-26 |
| CA2330833A1 (en) | 1999-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
| ATE358176T1 (de) | Menschliche dnase | |
| DE68924026D1 (de) | Biosensor und dessen herstellung. | |
| BR9506820A (pt) | Derivados de 4-amino de ácido micofenólico | |
| CA2301032A1 (en) | A method of preventing or treating estrogen-dependent diseases and disorders | |
| DE69901177D1 (de) | Platinkomplex, dessen herstellung und dessen therapeutische verwendung | |
| ID26861A (id) | Terapi gabungan untuk pengobatan depresi refaktori | |
| EP0292554A4 (de) | Feuchtigkeitsbeständiges hautbehandlungsmittel. | |
| IS5852A (is) | Lyfjamiðlar til meðhöndlunar á parkinsonsveiki ADHD og smákirtilsæxlum | |
| IS5056A (is) | Ný meðhöndlun á liðbólgu | |
| ATE267611T1 (de) | MENSCHLICHES ßMINOR VAULTß PROTEIN P193 | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| FR2716375B3 (fr) | Injecteur médical. | |
| DE69814993D1 (de) | Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen | |
| DE60239670D1 (de) | Verwendung von oxytocin zur herstellung einer pharmazeutischen zusammensetzung gegen karzinom in situ und zervizitis | |
| ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
| DE69910425D1 (de) | Neue therapeutische verwendung von nicergoline | |
| PT1056458E (pt) | Tratamento de dor cronica | |
| EA200200319A1 (ru) | Белок iren, его получение и использование | |
| ITRM920305A0 (it) | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. | |
| IL143279A0 (en) | Novel therapeutic application of low molecular weight heparin | |
| RU95114858A (ru) | Новый пептидный фрагмент, обладающий биологической активностью инсулина | |
| KR970023499U (ko) | 생물학적 순산소 개방형 폐수 처리장치 | |
| FR2713479B1 (fr) | Bassin médical. | |
| BR9710992A (pt) | Derivados anticovulsivos úteis no tratamento de psorìase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |